CervoMed Inc. (CRVO)
NASDAQ: CRVO · Real-Time Price · USD
8.69
-0.37 (-4.08%)
At close: Dec 5, 2025, 4:00 PM EST
8.85
+0.16 (1.84%)
After-hours: Dec 5, 2025, 7:26 PM EST
CervoMed Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for CervoMed stock have an average target of 21.5, with a low estimate of 15 and a high estimate of 31. The average target predicts an increase of 147.41% from the current stock price of 8.69.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for CervoMed stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 6 | 6 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $31 | Strong Buy | Maintains | $31 | +256.73% | Dec 5, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $31 | Strong Buy | Maintains | $31 | +256.73% | Dec 2, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $31 | Strong Buy | Maintains | $31 | +256.73% | Nov 11, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold → Strong Buy Upgrades $11 → $25 | Hold → Strong Buy | Upgrades | $11 → $25 | +187.69% | Nov 5, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $31 | Strong Buy | Maintains | $31 | +256.73% | Nov 4, 2025 |
Financial Forecast
Revenue This Year
5.26M
from 9.74M
Decreased by -45.96%
Revenue Next Year
1.10M
from 5.26M
Decreased by -79.06%
EPS This Year
-2.51
from -2.02
EPS Next Year
-2.01
from -2.51
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 7.3M | 5.0M | ||||
| Avg | 5.3M | 1.1M | ||||
| Low | 4.2M | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -24.5% | -4.2% | ||||
| Avg | -46.0% | -79.1% | ||||
| Low | -56.7% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -1.45 | -0.57 | ||||
| Avg | -2.51 | -2.01 | ||||
| Low | -2.90 | -2.83 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.